L. Corchete-Sánchez

Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial

N. Puig, A. Oriol, T. Paíno, 2020, Cancers.

Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice

J. Pérez-Losada, J. Cañueto, C. Román-Curto, 2019, Journal of the American Academy of Dermatology.

Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at Relapse

J. Hernández-Rivas, N. de Las Heras, J. Ribera, 2020, Diagnostics.

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose‐intensive chemotherapy including rituximab

L. Escoda, M. Tormo, J. Hernández-Rivas, 2016, British journal of haematology.

Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome

J. Hernández-Rivas, J. Rodríguez, J. Labrador, 2016, PloS one.

PERFORMANCE OF SALAMANCA'S REFINEMENT OF THE T3-AJCC8 VERSUS THE BRIGHAM AND WOMEN'S HOSPITAL AND TÜBINGEN ALTERNATIVE STAGING SYSTEMS FOR HIGH-RISK CUTANEOUS SQUAMOUS CELL CARCINOMA.

J. Cañueto, C. Román-Curto, L. Puebla-Tornero, 2020, Journal of the American Academy of Dermatology.

TMeB score may improve risk stratification of high‐risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study

M. Mendiburu-Eliçabe, J. Pérez-Losada, C. Schmults, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.